She is a member of international organisations and has 15 years of clinical expertise
Cytecare has appointed Dr Mythri Shankar as Senior Consultant, Nuclear Medicine Department. Dr Shankar has trained extensively in Nuclear Medicine from various global institutions such as UCLA, Cedars Sinai, Children’s Hospital of Los Angeles and Harvard Medical School.
With over 15 years of clinical expertise, Dr Shankar’s experience has enabled the integration of most appropriate protocol selection while performing sophisticated radioactive injection procedures. She is a member of several international organisations such as the American Society of Nuclear Cardiology and the (US and India), and is also actively involved in academics and several research projects.
She is a renowned Women’s Health Activist, an entrepreneur (IIM-B Alumini) and the Founder Trustee of Osteoporosis Foundation, India.
Suresh Ramu, CEO and Co-Founder, Cytecare Hospitals, said “We are delighted to have Dr Mythri Shankar on board as our Nuclear Medicine specialist. Targeted therapy with radiopharmaceuticals – radioactive compounds used in nuclear medicine for diagnosis or treatment has demonstrated superior clinical outcomes in trials for cancer treatment. Dr Mythri’s joining the team will definitely be a great impetus for the diagnostic and nuclear medicine-based therapy at Cytecare. With her specialised and research-based approach in nuclear medicine treatment.
- Advertisement -
Comments are closed.